Literature DB >> 10147353

Multivariate analysis of health status scores: chronic airway disorders and the MOS SF-36.

E R Cox1, C M Kozma, C E Reeder.   

Abstract

Multivariate analysis of variance (MANOVA) with follow-up canonical discriminant analysis may be used to interpret differences in health-related quality of life measured by the Medical Outcome Study Short Form 36 (MOS SF-36). Due to the moderate correlations between the 8 health dimensions of the SF-36, MANOVA is theoretically a more appropriate method than traditional univariate approaches for detecting group differences on the SF-36. Additionally, canonical discriminant analysis presents a novel approach to understanding the relationship between health dimensions of the SF-36 and model-independent variables. Results from the MANOVA and canonical discriminant analysis provide evidence of the sensitivity of the SF-36 in cross-sectional, self-reported data. Significant differences in health status (alpha less than or equal to 0.05) were found for the variables of age, and primary physician visits, and between levels of disease severity, type of breathing problem, whether patients had seen a specialist or not, use of emergency room, the comorbid states of depression and arthritis, and income. No significant differences in health status were reported between males and females or racial groups.

Entities:  

Mesh:

Year:  1994        PMID: 10147353     DOI: 10.2165/00019053-199406010-00006

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  12 in total

1.  Methods for assessing condition-specific and generic functional status outcomes after total knee replacement.

Authors:  M E Kantz; W J Harris; K Levitsky; J E Ware; A R Davies
Journal:  Med Care       Date:  1992-05       Impact factor: 2.983

2.  The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

Authors:  J E Ware; C D Sherbourne
Journal:  Med Care       Date:  1992-06       Impact factor: 2.983

3.  Ongoing assessment of health status in patients with diabetes mellitus.

Authors:  D R Nerenz; D P Repasky; F W Whitehouse; D M Kahkonen
Journal:  Med Care       Date:  1992-05       Impact factor: 2.983

4.  The validity and relative precision of MOS short- and long-form health status scales and Dartmouth COOP charts. Results from the Medical Outcomes Study.

Authors:  C A McHorney; J E Ware; W Rogers; A E Raczek; J F Lu
Journal:  Med Care       Date:  1992-05       Impact factor: 2.983

5.  Psychological factors contributing to disproportionate disability in chronic bronchitis.

Authors:  A D Morgan; D F Peck; D Buchanan; G J McHardy
Journal:  J Psychosom Res       Date:  1983       Impact factor: 3.006

6.  Relationships between general health measured with the sickness impact profile and respiratory symptoms, physiological measures, and mood in patients with chronic airflow limitation.

Authors:  P W Jones; C M Baveystock; P Littlejohns
Journal:  Am Rev Respir Dis       Date:  1989-12

7.  The impact of long-term warfarin therapy on quality of life. Evidence from a randomized trial. Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators.

Authors:  T R Lancaster; D E Singer; M A Sheehan; L B Oertel; S W Maraventano; R A Hughes; J P Kistler
Journal:  Arch Intern Med       Date:  1991-10

8.  The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups.

Authors:  C A McHorney; J E Ware; J F Lu; C D Sherbourne
Journal:  Med Care       Date:  1994-01       Impact factor: 2.983

9.  The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs.

Authors:  C A McHorney; J E Ware; A E Raczek
Journal:  Med Care       Date:  1993-03       Impact factor: 2.983

10.  Breathlessness and psychiatric morbidity in chronic bronchitis and emphysema: a study of psychotherapeutic management.

Authors:  R Rosser; J Denford; A Heslop; W Kinston; D Macklin; K Minty; C Moynihan; B Muir; L Rein; A Guz
Journal:  Psychol Med       Date:  1983-02       Impact factor: 7.723

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.